Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia

Clinical trial NCT00742144 · COMPLETED

Trial details

NCT number: NCT00742144
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular

Start date: 2008-09-19
Primary completion: 2009-11-18
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.